26 Result(s)

Article

Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors – first 10 years of prospective donor follow-up of Swiss donors

Since July 2007 prospective life-long follow-up (FU) for unrelated (URD) and related donors (RD) is mandatory in Switzerland and data on every allogeneic haematopoietic progenitor cell (HPC) donation are colle...

M. Rüesch, S. Amar el Dusouqui, E. Buhrfeind, A. Buser… in Bone Marrow Transplantation (2022)

Article

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities

Unrelated donor searches in Switzerland require high-resolution HLA ty** for HLA-A/B/C/DRB1/DRB3,4/DQB1 loci. We evaluated this strategy accepting donors with ⩾9/10 match. Of 802 unrelated donor transplants ...

J R Passweg, U Schanz, Y Chalandon, T Güngör, H Baldomero… in Bone Marrow Transplantation (2015)

Article

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

Several T-cell depletion (TCD) techniques are used for haploidentical hematopoietic SCT (HSCT), but direct comparisons are rare. We therefore studied the effect of in vitro TCD with graft engineering (CD34 select...

A Marek, M Stern, Y Chalandon, M Ansari, H Ozsahin, T Güngör… in Bone Marrow Transplantation (2014)

Article

The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable

Identification of an unrelated HLA allele-matched hematopoietic stem cell (HSC) donor is a costly and time-consuming procedure. To improve search logistics, we have limited the search period to 6 months and ha...

J-M Tiercy, G Nicoloso, J Passweg, U Schanz, R Seger… in Bone Marrow Transplantation (2007)

Article

Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland

It is currently unknown what degree of human leukocyte antigen (HLA)-mismatching is acceptable in unrelated donor hematopoietic stem cell transplantation (UD-HSCT). Mismatches at some loci may be more permissi...

Y Chalandon, J-M Tiercy, U Schanz, T Gungor, R Seger… in Bone Marrow Transplantation (2006)

Article

Gynecologic oncology

G. Oskav-Özcelik, H. J. Hindenburg, P. Klare… in Archives of Gynecology and Obstetrics (2005)

Article

Maternal fetal medicine-perinatology

C. Tekcan, M. M. Naki, N. Özcan, M. Cebi… in Archives of Gynecology and Obstetrics (2005)

Article

Urogynecology

E. Petri, R. Niemeyer, E. Petri, R. Niemeyer… in Archives of Gynecology and Obstetrics (2005)

Article

Menopause

L. Tutuncu, N. Arslanhan, A. R. Ergur, E. Mungen… in Archives of Gynecology and Obstetrics (2005)

Article

General gynecology

A. Salfelder, R. P. Lueken, C. Bormann… in Archives of Gynecology and Obstetrics (2005)

Article

Disseminated Fusarium oxysporum Infection in Hemophagocytic Lymphohistiocytosis

The portal of entry of disseminated Fusarium spp. infections is still not clearly defined. We report on a disseminated Fusarium oxysporum infection occurring during a long period of severe neutropenia in a child ...

M. Albisetti, R. P. Lauener, T. Güngör, G. Schär, F. K. Niggli, D. Nadal in Infection (2004)

Chapter and Conference Paper

Favorable Response to Protein C in Venoocclusive Disease after Allogeneous Stem Cell Transplantation

Hepatic venoocclusive disease (VOD; syn: sinusoidal obstruction syndrome) may be a severe, lethal early complication after stem cell transplantation (SCT) (Table 1; frequency of 24% in our patient cohort [see als...

S. Eber, F. Scherer, T. Güngör in 33^rd Hemophilia Symposium (2004)

Article

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

Veno-occlusive disease (VOD) of the liver is a complication observed particularly in patients undergoing hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is a polydeoxyribonucleotide with aptam...

S Corbacioglu, J Greil, C Peters, N Wulffraat, H J Laws… in Bone Marrow Transplantation (2004)

Article

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita

We describe the treatment of a 10-year-old girl with autosomal recessive Dyskeratosis congenita (DC), neutropenia, thrombocytopenia and combined immunodeficiency by nonmyeloablative hematopoietic stem cell tra...

T Güngör, S Corbacioglu, R Storb, R A Seger in Bone Marrow Transplantation (2003)

Article

A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m² as a optimal total dose for conditioning

We conducted a phase I/II trial, to evaluate the efficacy and safety of an intravenous liposomal formulation of busulphan (LBu) as a myeloablative agent for stem cell transplantation (SCT). The liposomal busul...

M Hassan, C Nilsson, Z Hassan, T Gungor, J Aschan… in Bone Marrow Transplantation (2002)

Article

Influence of gold mine on groundwater quality (Efemçukuru, Izmir, Turkey)

Currently, exploration of gold ores is under discussion in Turkey, without considering its adverse affect on the environment. Studying the adverse affect on environment is extremely important because significa...

A. Baba, T. Güngör in Environmental Geology (2002)

Article

Shwachman-Diamond syndrome: early bone marrow transplantation in a high risk patient and new clues to pathogenesis

Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterised by exocrine pancreas insufficiency, metaphyseal dysostosis and bone marrow dysfunction. Recurrent severe bacterial infections ...

J. Faber, R. Lauener, F. Wick, D. Betts, L. Filgueira… in European Journal of Pediatrics (1999)

Article

Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment

M. Schmugge, R. Lauener, W. Bossart, R. A. Seger… in European Journal of Pediatrics (1999)